| Literature DB >> 30901890 |
Amparo Tarrega1, Claude Yven2, Etienne Semon3,4, Patrick Mielle5, Christian Salles6.
Abstract
Temporal aroma compound release during eating is a function of the physicochemical properties of the food matrix, aroma compounds, and oral physiology of individuals. However, the influence of each parameter on the release of each aroma component should be clarified. Two flavored lipoprotein matrices varying in composition were chewed in a chewing simulator that reproduced most of the physiological functions of the mouth. Aroma compound releases (butanoic acid, 2-heptanone, ethyl butyrate, 3-octanone, and 2-nonanone) were followed in real time by direct connection of the device to APCI-MS (atmospheric pressure chemical ionization mass spectrometry). Each oral parameter was controlled and decoupled using the in vitro device. The food matrix composition had only a low impact on aroma compound release, but the controlled oral parameters had significantly different influences on the release of aroma compounds according to their physicochemical characteristics. The release of certain compounds seemed more sensitive to bite force, while others seemed more sensitive to the shearing angle. The salivary flow rate primarily influenced the more hydrophobic compounds. Significant interactions were also observed between shear angle, salivary flow rate, and lipoprotein matrix composition, mainly for the release of the more hydrophobic volatile compounds; this needs further investigations to be clarified.Entities:
Keywords: aroma compound; chewing simulator; flavor release; in vitro; lipoprotein matrix; oral parameters
Year: 2019 PMID: 30901890 PMCID: PMC6462901 DOI: 10.3390/foods8030106
Source DB: PubMed Journal: Foods ISSN: 2304-8158
Composition and characteristics of the lipoprotein matrix (LPM) samples (% of total mass).
| LPM 1 | LPM 2 | |
|---|---|---|
| Water (g) | 310 (62) | 275 (55) |
| Anhydrous milk fat (g) | 61.5 (12.3) | 110 (22) |
| Milk powder (g) | 123.5 (24.7) | 110 (22) |
| NaCl (g) | 5 (1) | 5 (1) |
| Aromatic solution a (mL) | 0.5 (0.1) | 0.5 (0.1) |
| Rennet b (mL) | 4.8 (0.96) | 4.8 (0.96) |
| Fat/Milk Protein powder | 0.5 | 1 |
|
| ||
| MD (kPa) | 32.78 * | 44.38 * |
| Df (-) | 0.42 | 0.40 |
| Cf (kPa) | 23.36 | 23.88 |
| Wf (kJ/m3) | 4.14 | 4.34 |
* Significantly different (F = 7.76; p = 0.022); a Composition: butanoic acid (10 µL), 2,3-butanedione (3 µL), 2-heptanone (5 µL), 2-nonanone (5 µL), 3-octanone (5 µL), ethyl hexanoate (5 µL), ethyl butanoate (4 µL), dimethyl disulphide (10 µL), and polyethyleneglycol up to 1 mL; b active chymosin 520 mg/L, dilution 1/10; MD: modulus of deformability, Df: fracture strain, Cf: fracture stress, Wf: fracture work.
Physiological results obtained for each subject during chewing LPM1 and LPM2.
| Subject | Product | Salivary Flow Rate (mL/s) | Chewing Duration (s) | Total Work of Muscle (mV s) | Number of Chewing Cycles | Mandible Force (daN) | Shearing Angle (°) |
|---|---|---|---|---|---|---|---|
| A | LPM1 | 13.5 ± 2.9 | 1.01 ± 0.31 | 25.0 ± 8.5 | 13.3 ± 1.1 | 2.6 ± 0.4 | |
| LPM2 | 4.0 ± 0.4 | 15.1 ± 4.9 | 1.06 ± 0.13 | 21.3 ± 4.0 | 11.5 ± 0.5 | 2.7 ± 0.6 | |
| B | LPM1 | 23.1 ± 6.7 | 3.48 ± 0.25 | 33.7 ± 7.0 | 21.6 ± 1,5 | 5.0 ± 0.5 | |
| LPM2 | 2.8 ± 0.2 | 24.9 ± 0.7 | 3.75 ± 0.23 | 38.0 ± 0 | 20.4 ± 0.5 | 4.7 ± 0.5 | |
| C | LPM1 | 28.0 ± 2.4 | 2.92 ± 0.19 | 39.0 ± 3.6 | 16.4 ± 0.4 | 3.1 ± 1.5 | |
| LPM2 | 3.5 ± 0.2 | 23.7 ± 0.8 | 2.60 ± 0.16 | 33.7 ± 3.1 | 16.9 ± 0.8 | 3.0 ± 0.3 |
LPM1: lipoprotein matrix with 0.5 fat/milk protein ratio; LPM2: lipoprotein matrix with 1 fat/milk protein ratio; 3 replicates for each of the 3 subjects (A, B and C).
Figure 1Chewing simulator connected to the atmospheric pressure chemical ionization mass spectrometer (APCI-MS) for online and real time analyses of aroma compound release under in vitro mastication conditions with details of the gas sampling valve.
In vivo aroma compound release. Fisher statistics from Analyses of Variance (ANOVA) of the temporal aroma compound release parameters. Only significant results (p < 0.05) are reported. Cmax: maximum released concentration; RR: release rate; LPM: lipoprotein matrix.
| Ions ( | Release Parameters | F |
| Subject Effect |
|---|---|---|---|---|
| 89 | Cmax | 5.66 | 0.018 | B > (C = A) |
| RR | 7.44 | 0.007 | B > (C = A) | |
| 115 | Cmax | 7.71 | 0.007 | (B = C) > A |
| RR | 9.36 | <0.001 | B > (C = A) | |
| 117 | Cmax | 5.47 | 0.021 | B ≥ C ≥ A (B > A) |
| RR | 5.44 | 0.021 | B ≥ A ≥ C (B > C) | |
| 129 | Cmax | 5.98 | 0.015 | C ≥ B ≥ A (C > A) |
| RR | 7.98 | 0.006 | (B = A) > C | |
| 143 | Cmax | 5.88 | 0.016 | (B = C)> A |
| RR | 7.34 | 0.008 | B ≥ A ≥ C (B > C) | |
| RR | 9.31 | 0.003 | Subject*LPM: B-LPM2 > B-LMP1 | |
| 145 | RR | 4.58 | 0.033 | B ≥ A ≥ C (B > C) |
m/z: mass/charge ratio; m/z 89 (Butanoic acid); m/z 115 (2-Heptanone); m/z 117 (Ethyl butanoate); m/z 129 (3-Octanone); m/z 143 (2-Nonanone); m/z 145 (Ethyl hexanoate). F: Fisher value calculated by ANOVA; * indicates interaction between parameters.
Figure 2Example of in vitro temporal aroma compound release curves obtained by online coupling of the chewing simulator with the APCI-MS apparatus (3 replicates). (A) The total ionic current presented in ordinate is representative of the overall volatile compounds concentration in the gas phase according to the time. (B) Ionic current intensity for each detected ion in function of the chewing time. Conditions: initial volume of saliva: 1 mL; salivary flow rate: 1 mL/min; compression force: 25 DaN; shearing angle: 3°. Volatile compounds in lipoprotein matrices (µL/kg): butanoic acid (10); 2,3-butanedione (3); 2-heptanone (5); 2-nonanone (5); 3-octanone (5); ethyl hexanoate (5); ethyl butanoate (4); dimethyldisulphide (10). Ions: m/z 117 (ethylbutanoate); m/z 89 (butanoic acid); m/z 115 (2-heptanone); m/z 129 (3-octanone); m/z 145 (ethylhexanoate); m/z 143 (2-nonanone).
In vitro aroma compound release from lipoprotein matrices. Fisher statistics from Analyses of Variance (ANOVA) of the temporal aroma compound release parameters. Only significant results (p < 0.05) are reported. Cmax: maximum released concentration; RR: release rate; LPM: lipoprotein matrix; BF: bite force; SA: shearing angle; SF: salivary flow rate.
| Compound | Butanoic Acid | Ethyl Butanoate | 2-Heptanone | Ethyl Hexanoate | 3-Octanone | 2-Nonanone | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
| 89 | 115 | 117 | 145 | 129 | 143 | |||||||
| Cmax | RR | Cmax | RR | Cmax | RR | Cmax | RR | Cmax | RR | Cmax | RR | ||
| BF | F | 15.77 | 7.09 | 5.02 | 26.56 | ||||||||
| 0.0005 | 0.0139 | 0.0356 | <0.0001 | ||||||||||
| SA | F | 23.10 | 12.51 | 8.92 | 9.17 | 5.22 | |||||||
| <0.0001 | 0.0017 | 0.0064 | 0.0058 | 0.0315 | |||||||||
| SF | F | 13.89 | 7.24 | 13.30 | 6.30 | ||||||||
| <0.0001 | 0.0035 | 0.0001 | 0.0063 | ||||||||||
| LPM*SA | F | 6.04 | |||||||||||
| 0.0216 | |||||||||||||
| LPM*SF | F | 6.11 | 7.19 | 6.20 | 6.95 | ||||||||
| 0.0213 | 0.031 | 0.0201 | 0.0145 | ||||||||||
| SF*SA | F | 5.59 | 5.55 | 5.62 | 5.97 | ||||||||
| 0.0101 | 0.0105 | 0.0099 | 0.0078 | ||||||||||
m/z: mass/charge ratio; Log P: hydrophobicity of the aroma compounds (calculated with BIOVIA™ discovery studio software (version 2017, BIOVIA™ Corporate Europe, Cambridge, UK) according to Ghose et al. [47]. F: Fisher value calculated by ANOVA; * indicates interaction between parameters.